Related Books

Council on Competitiveness and FDA Plans to Alter the Drug Approval Process at FDA
Language: en
Pages: 364
Authors: United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee
Categories: Medical
Type: BOOK - Published: 1993 - Publisher:

GET EBOOK

Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
Language: en
Pages: 335
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2010-06-25 - Publisher: National Academies Press

GET EBOOK

Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, bu
Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development
Language: en
Pages: 118
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2012-04-04 - Publisher: National Academies Press

GET EBOOK

The development and application of regulatory science - which FDA has defined as the science of developing new tools, standards, and approaches to assess the sa
Report to the White House
Language: en
Pages: 272
Authors: United States. Interagency Committee on New Therapies for Pain and Discomfort
Categories: Hospice care
Type: BOOK - Published: 1979 - Publisher:

GET EBOOK

Rare Diseases and Orphan Products
Language: en
Pages: 442
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2011-04-03 - Publisher: National Academies Press

GET EBOOK

Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions i